At Aragen, we work closely with clients to deliver customised therapeutic cell line development solutions. We specialize in difficult to express proteins, and our mammalian host cell lines are primarily developed in Chinese Hamster Ovary (CHO) cells for the production of recombinant protein products of interest. A majority of clients leverage the decades of experience we have with our inhouse CHO-DG44 platform, which delivers a royalty free, low risk option for the scalable manufacture of proteins within a cGMP environment. We also have significant expertise in multiple mammalian expression platforms, including CHO-S, CHO-GS, CHO-DuxB11 and CapT, among others.
Aragen is a non-GMP service provider, but we routinely transfer cell lines to GMP facilities, globally.